The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture of pharmaceutical preparations
150 jobs Number of planned job creations
Announcement Date
18 May 2015
Employment effect (start)
Foreseen end date
Description
Anglo-Swedish pharmaceutical company AstraZeneca is to hire between 150 and 250 new workers by 2019 at one of the company's sites in Gärtuna outside Södertälje(Sweden).
AstraZeneca recently announced an investment worth SEK 2,3 billion (€ 245 million) in a new high-tech facility for biological drugs in Södertälje. The facility is estimated to require between 150 and 250 highly skilled workers.
Eurofound (2015), AstraZeneca, Business expansion in Sweden, factsheet number 83060, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/83060.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
